Key result
Intradialytic resistance training improved blood pressure most in ACE DD homozygotes, whereas allele I carriers displayed a higher increase in muscle mass.
Why the study?
The study aimed to verify the influence of the ACE I/D genotype on blood pressure, muscle mass, and redox balance responses to long-term resistance training in patients with end-stage renal disease.
Does the ACE I/D genotype influence the blood pressure, muscle mass, and redox balance response to long-term intradialytic resistance training in patients with end-stage renal disease?
RCT (n=320)
Randomized into 4 groups
Does the ACE I/D genotype influence the blood pressure, muscle mass, and redox balance response to long-term intradialytic resistance training in patients with end-stage renal disease?
The ACE I/D genotype significantly influences the physiological adaptations to intradialytic resistance training in end-stage renal disease, with DD homozygotes experiencing greater blood pressure reductions and allele I carriers gaining more muscle mass.
Answers are grounded in this paper and cite their sources.
ACE I/D genotype may guide intradialytic training to optimize BP or muscle outcomes in ESRD; extends personalized exercise evidence from RCTs.
Corrêa, HdL, Deus, LA, Neves, RVP, Reis, AL, de Freitas, GS, de Araújo, TB, da Silva Barbosa, JM, Prestes, J, Simões, HG, Amorim, CE, dos Santos, MAP, Haro, A, de Melo, GF, Gadelha, AB, Neto, LS, and Rosa, TdS. Influence of angiotensin converting enzyme I/D polymorphism on hemodynamic and antioxidant response to long-term intradialytic resistance training in patients with chronic kidney disease: a randomized controlled trial. J Strength Cond Res 35(10): 2902-2909, 2021-The aim of the study was to verify the influence of Angiotensin-converting enzyme (ACE) I/D genotype on blood pressure, muscle mass, and redox balance response to long-term resistance training (RT) in end-stage renal disease patients. Three hundred and twenty subjects were randomized into 4 groups: II + ID control (II + ID CTL, n = 80), II + ID RT (II + ID RT, n = 79), DD control (DD CTL n = 83), and DD RT (DD RT, n = 78). The RT lasted 24 weeks with a frequency of 3 times per week, on alternative days. Each section consisted of 3 sets of 8-12 repetitions in 11 exercises, with training loads at 6 point (somewhat hard) to 8 point (hard) based on OMNI-RES scale and was prescribed during dialysis (intradialytic). Statistical significance was accepted with p < 0.05. The most relevant benefits in blood pressure were found for DD homozygotes (p < 0.0001), whereas allele I carriers displayed a higher increase in muscle mass (p < 0.0001). Hemodialysis clinics that already use RT for their patients could include the genotyping of ACE to identify the predisposal of the patients to respond to RT and to counteract kidney disease-related comorbidities.
No takes yet. Share an insight, caveat, or question.
Corrêa et al. (2021) conducted an RCT in End-stage renal disease (n=320). Intradialytic resistance training vs. Control was evaluated on Blood pressure, muscle mass, and redox balance (p=<0.0001). Intradialytic resistance training improved blood pressure most in ACE DD homozygotes, whereas allele I carriers displayed a higher increase in muscle mass.
Synapse has enriched 10 related papers. Consider them for comparative context: